Company profile
InMed Pharmaceuticals Inc.
NASDAQ:INMBiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04908215 | phase2 | completed | 2021-12-28 | 2023-04-03 | InMed Pharmaceuticals Inc. | INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa |
FDA applications (0)
No records yet.